BioVaxys Trading Halted Amid Filing Delay
Company Announcements

BioVaxys Trading Halted Amid Filing Delay

Biovaxys Technology Corp (TSE:BIOV) has released an update.

BioVaxys Technology Corp. has been hit with a cease trade order by the Ontario Securities Commission due to a delay in filing their financial statements and other regulatory documents. The company is now barred from trading in Canada until they fulfill their overdue filing obligations for the annual and interim periods ending October 2023 and January 2024, respectively. BioVaxys is actively working to resolve these issues and expects to file the required documents soon to lift the trading restrictions.

For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBioVaxys Technology Bolsters Funds and Settles Debt
TipRanks Canadian Auto-Generated NewsdeskBioVaxys Secures US Patent for Innovative Vaccine Delivery
TipRanks Canadian Auto-Generated NewsdeskBioVaxys Hires Expert CPA as Business Advisor
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!